Market Place
Sourcing Support
Laurus Labs Generic Abacavir Sulfate Receives Approval in the U.S.
25 Jul 2022 //
FDA
The Food and Drug Administration approved revisions to the TRIUMEQ
12 Mar 2021 //
FDA
5 FDA-approved antivirals could target COVID-19: study
02 Jul 2020 //
FIERCE BIOTECH
New Paragraph IV Certifications as of April 7, 2020
08 Apr 2020 //
FDA
ViiV Healthcare Submits Supplemental New Drug Application to US FDA
16 Oct 2019 //
BUSINESSWIRE
ViiV’s Dovato wins US approval PRV, empowering GSK to muscle Gilead’s HIV empire
10 Apr 2019 //
ENDPTS
List of Paragraph IV Patent Certifications Feb-12, 2019
13 Feb 2019 //
FDA
List of New Paragraph IV Certifications as of Aug 21, 2018
21 Aug 2018 //
FDA
Aurobindo Pharma`s Generic Abacavir Sulfate Receives Approval In US
15 Mar 2018 //
FDA
Cipla’s Generic Abacavir Sulfate Receives Approval In US
23 Nov 2017 //
FDA
Aurobindo Pharma’s Generic Abacavir Sulfate; Lamivudine Receives Approval US
28 Mar 2017 //
FDA
Lupin’s Generic Abacavir Sulfate; Lamivudine Receives Approval US
28 Mar 2017 //
FDA
Cipla’s Generic Abacavir Sulfate; Lamivudine Receives Approval In US
28 Mar 2017 //
FDA
Lupin Gains on Tentative Approval for Generic Epzicom Tablets
23 Nov 2016 //
BUSINESS STANDARD
Hetero Labs Ltd III Generic Abacavir Sulfate Approved In US
26 Sep 2016 //
FDA
The top 20 drugs in 2020--worldwide sales
22 Feb 2016 //
FIERCE PHARMA
GSK`s HIV bright spot could get brighter with new Tivicay combo meds
04 Nov 2015 //
FIERCE PHARMA MARKETING
ViiV boosted by positive phase III results for HIV drug Triumeq
23 Sep 2015 //
PM LIVE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.